Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
about
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapyBiological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy.Lithium inhibits tumorigenic potential of PDA cells through targeting hedgehog-GLI signaling pathway.MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.GSK3β mediates the carcinogenic effect of HPV16 in cervical cancerAberrant glycogen synthase kinase 3β in the development of pancreatic cancer.Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cellsMetabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.Comparative analysis of Notch1 and Notch2 binding sites in the genome of BxPC3 pancreatic cancer cells.MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-cateninGlycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy.GSK-3 inhibition overcomes chemoresistance in human breast cancer.Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma.Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway.Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells.9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma.
P2860
Q26739711-3D082BF6-BBF2-41F3-B3B9-4B815737EDBEQ33618479-8CA1D66A-96CE-44FF-81BB-EFC40DDFF835Q34585992-3C9AAA4B-5490-4416-97FB-9D387CDE28E5Q34692166-53D4BB9D-35F6-4DDA-A010-9A961C571D57Q35987380-96BB0F2B-7543-4B02-9B74-777C804313FDQ36272771-18DCB093-B812-4D79-B2B6-328389F153F5Q36450022-AF65F3EE-C670-4C7C-992C-F158F9D6BF01Q36559874-C915DC32-7088-469F-A90E-ACAF1DDA0478Q37129787-C922EE18-79F7-49D5-BD83-CD25A287C4CEQ37139199-F952E65C-1AC2-459C-8C4D-F2D6894CD040Q37604313-FC2E36E3-F95C-44CA-8E8C-0030D98E4CB0Q37706915-90684760-E619-4D9B-A76E-9F4191BB331AQ37718335-D0071FA6-4E5B-49B1-B279-E55D2EEDD1B3Q38221504-8C4DB584-7B9E-488E-BB75-D5B14C701C8BQ38757733-9C7077A1-1C84-4124-A42B-FE531911E193Q38957259-09AFD185-9380-4DF0-B53E-E3259884782FQ39129195-62EE7C4D-2B84-43B1-BE2F-654A507054B9Q42383020-896869EC-0929-4E01-8999-FACC301C7C2EQ54977208-6689CE8E-C06D-4FEB-96D9-2627DD049301Q54977695-31593593-397D-4517-8E44-4914D3BC3700
P2860
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@en
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@nl
type
label
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@en
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@nl
prefLabel
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@en
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@nl
P2093
P2860
P1476
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
@en
P2093
Ayako Kitano
Hideo Nakajima
Itaru Sato
Kazuyuki Kawakami
Naohisa Tomosugi
Naoki Nakaya
Takanobu Takata
Takeo Shimasaki
Takuji Tanaka
Toshinari Minamoto
P2860
P304
P356
10.1007/S00535-011-0484-9
P577
2011-11-01T00:00:00Z